Tourmaline Bio, Inc.
TRMLDelisted Oct 28, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827506
Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Tourmaline Bio, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 92 | 101 | +9 |
| Shares | 21.0M | 22.9M | +1.83M (+8.7%) |
| Value | $540.7M | $463.6M | −$77.1M (−14.3%) |
New holders (22)
Institutions that held Tourmaline Bio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pfizer Inc | 1,272,214 | $25.8M | 1.00% |
| Adage Capital Partners GP, L.L.C. | 600,000 | $12.2M | 0.02% |
| Polymer Capital Management (HK) LTD | 79,400 | $1.61M | 0.28% |
| Rafferty Asset Management, LLC | 29,844 | $605.2K | 0.00% |
| American Century Companies Inc | 23,357 | $473.7K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 23,044 | $467.3K | 0.01% |
| Wexford Capital LP | 20,610 | $418.0K | 0.11% |
| Swiss National Bank | 20,100 | $407.6K | 0.00% |
| State of Wisconsin Investment Board | 17,793 | $360.8K | 0.00% |
| Intech Investment Management LLC | 10,214 | $207.1K | 0.00% |
| Gsa Capital Partners LLP | 10,198 | $207.0K | 0.02% |
| Police & Firemen's Retirement System of New Jersey | 5,564 | $112.8K | 0.00% |
| Virtus ETF Advisers LLC | 3,157 | $64.0K | 0.03% |
| KLP Kapitalforvaltning AS | 2,300 | $46.6K | 0.00% |
| Skopos Labs, Inc. | 1,576 | $32.0K | 0.01% |
| Federated Hermes, Inc. | 923 | $18.7K | 0.00% |
| GF Fund Management Co. Ltd. | 538 | $10.9K | 0.00% |
| Creative Planning | 109 | $2.21K | 0.00% |
| Amundi | 38 | $760 | 0.00% |
| SRS Capital Advisors, Inc. | 30 | $609 | 0.00% |
| Rothschild Investment LLC | 25 | $507 | 0.00% |
| SBI Securities Co., Ltd. | 3 | $61 | 0.00% |
Sold out (13)
Institutions that held Tourmaline Bio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Point72 Asset Management, L.P. | 338,437 | $8.70M |
| Eversept Partners, LP | 84,380 | $2.17M |
| Superstring Capital Management LP | 29,104 | $748.3K |
| DAFNA Capital Management LLC | 19,110 | $491.3K |
| Algert Global LLC | 12,112 | $311.4K |
| ADAR1 Capital Management, LLC | 11,260 | $289.5K |
| Two Sigma Advisers, LP | 10,119 | $260.2K |
| Manufacturers Life Insurance Company, The | 8,804 | $226.4K |
| Cresset Asset Management, LLC | 7,944 | $204.2K |
| Price T Rowe Associates Inc | 7,753 | $200.0K |
| AlphaCentric Advisors LLC | 5,500 | $141.4K |
| Catalyst Funds Management Pty Ltd | 200 | $5.14K |
| Russell Investments Group, Ltd. | 33 | $848 |